European dermatology forum: Updated guidelines on the use of extracorporeal photopheresis 2020 – Part 2

BACKGROUND: Following the first investigational study on the use of extracorporeal photopheresis for the treatment of cutaneous T‐cell lymphoma published in 1983, this technology has received continued use and further recognition for additional earlier as well as refractory forms. After the publicat...

Descripción completa

Detalles Bibliográficos
Autores principales: Knobler, R., Arenberger, P., Arun, A., Assaf, C., Bagot, M., Berlin, G., Bohbot, A., Calzavara‐Pinton, P., Child, F., Cho, A., French, L.E., Gennery, A.R., Gniadecki, R., Gollnick, H.P.M., Guenova, E., Jaksch, P., Jantschitsch, C., Klemke, C., Ludvigsson, J., Papadavid, E., Scarisbrick, J., Schwarz, T., Stadler, R., Wolf, P., Zic, J., Zouboulis, C., Zuckermann, A., Greinix, H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Guidelines and Position Statements
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7821314/
https://www.ncbi.nlm.nih.gov/pubmed/32964529
http://dx.doi.org/10.1111/jdv.16889

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7821314/
https://www.ncbi.nlm.nih.gov/pubmed/32964529
http://dx.doi.org/10.1111/jdv.16889

Ejemplares similares